Thomas Vanhecke is a Cardiology physician. OpenAlex indexes 47 publications with 786 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3452 Genesys Pkwy
Grand Blanc, MI 484397334
Telephone
810-606-7550Registry record last updated 21 Aug 2013.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.2%Beta blocker18%Metoprolol Succinate50%Metoprolol Tartrate29%Carvedilol21%Part D≥86 patientsStatin10%Atorvastatin Calcium80%Rosuvastatin Calcium16%Simvastatin5%Part D<11 patients+ 16 more classes in this area
Blood & clotting
16.4%Factor Xa inhibitor13%Eliquis83%Xarelto17%Part D≥78 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D≥22 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.7%Potassium supplement2.1%Potassium Chloride100%Part D≥25 patientsSGLT2 inhibitor0.6%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-10133-ACC MYOCARDIAL INFARCTION AND PULMONARY HYPERTENSION: DO AGE AND GENDER SHAPE MORTALITY TRENDS IN UNEXPECTED WAYS?
Journal of the American College of Cardiology
2026 - 26-A-10078-ACC ISCHEMIC HEART DISEASE AND OPIOID RELATED MORTALITY: UNVEILING THE HIDDEN CARDIOVASCULAR CONSEQUENCES OF THE OPIOID EPIDEMIC (2000-2020)
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”